Picture of Genprex logo

GNPX Genprex Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Genprex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
C2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-19.6-23.7-30.9-21.1-16.2
Depreciation
Non-Cash Items4.284.735.414.081.05
Other Non-Cash Items
Changes in Working Capital1.011.360.698-0.121-0.135
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Cash from Operating Activities-14.3-17.6-24.7-17.1-15.3
Capital Expenditures-0.072-0.06-0.0710
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.011000.0010
Sale of Fixed Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-0.084-0.06-0.0710.0010
Net Issuance / Retirement of Stock
Cash from Financing Activities25.70.00610.61221.5
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash11.3-17.7-14.2-5.146.23